SimpleGene Tech

SimpleGene Tech is a pioneering company dedicated to the development of high-throughput gene editing tools, catering to the realms of novel drug research and fundamental scientific exploration. Our mission is to create the most user-friendly CRISPR gene knockout tools, liberating research professionals from the complexities of viral packaging, plasmid preparation, Cas9 protein concentration testing, and other optimization experiments. With our automated high-throughput gene knockout platform, we have successfully validated knockouts for tens of thousands of genes in human primary cells, achieving over 80% efficiency in more than 70% of targeted genes.

 

In the rapidly advancing field of gene editing, SimpleGene Tech stands at the forefront, providing essential solutions for drug target discovery and validation, gene function studies, and gene therapy. Our globally recognized RNP gene knockout method has surpassed traditional Lentivirus and plasmid methods, emerging as the preferred choice for high-throughput gene knockout.

 

SimpleGene Tech boasts automated and high-throughput gene knockout standardization production platforms, capable of delivering hundreds of highly efficient KO cells every month. Our human whole-genome array knockout library has undergone rigorous high-content screening and validation, with over 80% of target genes achieving knockout efficiency of 70% or more.

 

In addition to our gene knockout expertise, SimpleGene Tech offers solutions for gene knockdown based on comprehensive human whole-genome knockout experimental data and extensive bioinformatics support. Our inducible shRNA knockdown cell lines enable precise and transcriptional-level targeted gene silencing, providing simplicity and repeatability in experiments.

 

Furthermore, our gene knock-in platform, built upon cutting-edge high-throughput gene insertion technology, facilitates the rapid construction of report cell lines for drug target confirmation, lead compound screening, and drug mechanism research. SimpleGene Tech is committed to accelerating progress in basic research and pharmaceutical development by delivering high-quality cell products and customized services.

 

At SimpleGene Tech, we blend simplicity with innovation, providing advanced solutions for the ever-evolving landscape of gene editing and contributing to breakthroughs in biomedical research and drug development.